Stockscreener 앱 받기
89.50
2.08%
1.82
시간 외 거래:
89.34
-0.16
-0.18%
Merck Co Inc 주식(MRK)의 최신 뉴스
The Surprising Attraction of High-Priced Stocks: Why Insiders Are Betting on Merck - Jomfruland.net
Why Insiders Are Snapping Up These Expensive Stocks: A Deep Dive Into Merck & Co. - Reporteros del Sur -
Merck & Co., Inc. (MRK): Among the Most Expensive Stocks Insiders Are Buying Recently - MSN
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - StreetInsider.com
Why Merck (MRK) is a Great Dividend Stock Right Now - Yahoo Finance
Hyperlipidemia Drugs Market Size to Promote USD 31.49 Bn by 2034 - GlobeNewswire Inc.
INVESTOR ALERT: Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Financial Times
MRK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit. - Markets Insider
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionMRK - Markets Insider
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck & Co., - GlobeNewswire
Merck president Johannes Oosthuizen sells $714,744 in stock - Investing.com
Shareholders that lost money on Merck & Co., Inc.(MRK) - GlobeNewswire
Redburn Atlantic Adjusts Price Target on Merck to $115 From $148, Maintains Buy Rating - Marketscreener.com
Merck & Co., Inc. Sued for Securities Law ViolationsContact The Gross Law Firm Before April 14, 2025 to Discuss Your RightsMRK - PR Newswire
MERCK & CO., INC. (NYSE: MRK) INVESTOR ALERT: Investors - GlobeNewswire
LA Gardasil Trial Against Merck Bagged After 3 Weeks - Law360
MERCK & CO., INC. (NYSE: MRK) INVESTOR ALERT: Investors With Large Losses in Merck & Co., Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights - TradingView
Merck vaccine trial delayed as RFK Jr. link creates jury concern - Los Angeles Times
August 15th Options Now Available For Merck (MRK) - Nasdaq
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - GlobeNewswire
Merck & Co. digs into 'junk DNA' for cancer clues in new Epitopea deal - FirstWord Pharma
Merck, Lilly launch manufacturing R&D consortium to help ‘bolster’ U.S. production - PharmaVoice
Merck & Co. Stockholder Notice: Shareholder Rights Law Firm - GlobeNewswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - Markets Insider
Merck & Co., Inc. (MRK): Among the Cheap High Dividend Stocks to Invest In Now - Insider Monkey
Merck Agrees to Halt Gardasil Trial Until September -February 18, 2025 at 03:19 pm EST - Marketscreener.com
MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit - Marketscreener.com
Merck cancer drug Welireg approved in EU (MRK:NYSE) - Seeking Alpha
Investors in Merck & Co., Inc. Should Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights – MRK - GlobeNewswire
Investors in Merck & Co., Inc. Should Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights – - EIN News
Looking Into Merck & Co's Recent Short Interest - Benzinga
Gilead upped on HIV franchise; Merck downgraded on Keytruda LoE at Deutsche Bank - Seeking Alpha
Is Merck & Co., Inc. (MRK) the Best Very Cheap Stock To Buy Right Now? - Yahoo Finance
Europe Approves Merck's Cancer Drug For Two Indications - Yahoo Finance
Exclusive-Merck vaccine case linked to HHS Secretary Kennedy delayed, company says - Marketscreener.com
Merck Gets Conditional Approval in EU for Drug Treating Von Hippel-Lindau Disease - Marketscreener.com
DBS Bank Adjusts Price Target on Merck to $100 From $168 -February 18, 2025 at 10:23 am EST - Marketscreener.com
MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Merck: EU approves WELIREG treatment -February 18, 2025 at 10:16 am EST - Marketscreener.com
Beyond The Numbers: 13 Analysts Discuss Merck & Co Stock - Benzinga
Deutsche Bank Downgrades Merck to Hold From Buy, Cuts Price Target to $105 From $128 - Marketscreener.com
Merck & Co., Inc. (MRK): Among the Best Drug Stocks to Buy Now - Insider Monkey
Merck's SWOT analysis: stock faces challenges amid gardasil setback, pipeline potential - Investing.com
Merck Downgrade Sparks Urgent Investor Decisions: Time to Shift Focus? - MotoPaddock
MRK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
Jim Cramer Comments on Merck & Co., Inc. (MRK) and Its China Woes - MSN
Is Merck & Co., Inc. (MRK) the Most Oversold S&P 500 Stock in 2024? - Yahoo Finance
MRK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Insider trades: Merck, McDonald's among notable names this week (NYSE:MRK) - Seeking Alpha
MRK INVESTOR NOTICE: Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
Accretive Wealth Partners LLC Makes New $531,000 Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Acquired by Empire Life Investments Inc. - MarketBeat
Rhumbline Advisers Cuts Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Valeo Financial Advisors LLC Has $8.83 Million Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Red Cedar Investment Management LLC - MarketBeat
PUREfi Wealth LLC Takes $312,000 Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Adell Harriman & Carpenter Inc. Decreases Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Position Lifted by Quadrant Private Wealth Management LLC - MarketBeat
1.90%
자본화:
|
볼륨(24시간):